MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cerebellar Ataxia as a Manifestation of Hashimoto Encephalopathy

S. Thakolwiboon, D. Ruthirago, V. Senanarong (Lubbock, TX, USA)

Meeting: 2018 International Congress

Abstract Number: 634

Keywords: Ataxia: Clinical features, Ataxia: Etiology and Pathogenesis, Ataxia: Treatment

Session Information

Date: Sunday, October 7, 2018

Session Title: Ataxia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To characterize the clinical, laboratory and radiologic findings as well as prognosis of Hashimoto encephalopathy (HE) presenting with cerebellar ataxia

Background: HE is a rare condition presenting with a variety of neurologic and psychiatric features. Cerebellar ataxia has also been reported as one of the common manifestations of HE. However, the clinical characteristics of ataxic variant of HE has not been described.

Methods: We retrospectively reviewed clinical charts of 204 unexplained encephalopathic patients. Fourteen HE patients were identified by the proposed diagnostic criteria by Graus and colleagues in 2016.(1)

Results: Cerebellar ataxia was found in 7 HE patients (50%) in this cohort. The median age at onset was 46 years (range, 22-77 years). There was a preponderance of female patients (71%). Four patients (57%) had cerebellar ataxia as the first manifestation. The median onset of encephalopathy was 4.5 weeks (range, 2-10 weeks) after ataxia. Two patients (29%) had the onsets of cerebellar ataxia and encephalopathy at the same time. Encephalopathy preceded ataxia in only 1 patient (14%). Serum anti-thyroperoxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies were positive in 6 (86%) and 4 (57%), respectively. Two patients (29%) had positive results for both antibodies. All of patients were euthyroidism. Regarding cerebrospinal fluid (CSF), only 2 patients (29%) had elevated protein level and pleocytosis. Six patients had abnormal magnetic resonance imaging (MRI) in cerebellum and its connections. Increased signal on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images in cerebellar white and gray matter were observed in 3 (43%) and 2 (29%), respectively. One patient (14%) had cerebellar atrophy. All patients received high-dose intravenous methylprednisolone for 3-5 days, then oral prednisolone which was tapered down very slowly. Median (range) of the Modified Rankin Scale (MRS) at presentation, discharge, and 3-month follow up were 4 (1-5), 2 (0-4), and 1 (0-2), respectively.

Conclusions: Cerebellar ataxia is a common presentation of HE which is a treatable condition. Cerebellar ataxia preceded the encephalopathic features in most of the case. Therefore, identification of HE by anti-TPO and anti-TG testing should be highly considered as a part of the cerebellar ataxia work up.

References: 1. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016;15(4):391-404.

To cite this abstract in AMA style:

S. Thakolwiboon, D. Ruthirago, V. Senanarong. Cerebellar Ataxia as a Manifestation of Hashimoto Encephalopathy [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/cerebellar-ataxia-as-a-manifestation-of-hashimoto-encephalopathy/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cerebellar-ataxia-as-a-manifestation-of-hashimoto-encephalopathy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley